Adial pharmaceuticals awarded notice of allowance for key patent combining use of the company's proprietary genetic diagnostic with ad04 to treat alcohol and drug dependence

Allowed claims cover the detection of select genotypes for use of ad04 to treating aud and oud patients allowed claims cover the detection of select genotypes for use of ad04 to treating aud and oud patients
ADIL Ratings Summary
ADIL Quant Ranking